OPCO Fireside Chat
Slides from the OPCO Fireside Chat
AAPS VCU Chapter Webinar
GastroPlus applications to various drug delivery routes of administration.
Novel Clinical Trial Designs for Optimizing Parameter Estimation in Malaria Disease-Drug Models
An introduction to Model-Informed Drug Development (MIDD) for Malaria and Volunteer Infection Studies (VIS)
Hepatotoxicity of Compound V Evaluated with Quantitative Systems Toxicology
Compound V is a small molecule with potential therapeutic benefits in patients with obesity.
Quantitative Systems Toxicology (QST) Modeling of Drug-Induced Liver Injury and Adaptation
This talk will present how quantitative systems toxicology (QST) modeling can aid in evaluating potential drug-drug interactions.
Prediction of midazolam pediatric plasma profiles for multiple routes of administration using physiologically based pharmacokinetic model
Owing to ethical and logistical constraints, clinical investigation of drugs in the pediatric population is challenging.
Utilization of PBBM/PBPK Models for Building a Safe Space and Regulatory Applications in Support of Drug Product Quality
Drug products undergo many chemistry, manufacturing, and control (CMC) changes throughout their lifecycle, making the overall process costly and time consuming.
DILIsym: Modeling Drug-Induced Liver Injury & Beyond
DILIsym Services, Inc. (DSSI) is a Simulations Plus company...
QST Applications, Use of Data and Species Differences
DILIsym Services, Inc. (DSSI) is a Simulations Plus company..
DILIsym Simulations Support the Liver Safety of Ubrogepant in New Toxicological Sciences Publication
Dr. Paul B. Watkins and Dr. Jeff Woodhead discuss the DILIsym analysis of the latest publication in Toxicological Sciences! Small-molecule calcitonin gene...
Modeling DILI Drug-Drug Interactions with DILIsym
DILIsym Services, Inc. offers comprehensive program services:
Physiologically Based Biopharmaceutics Modeling and Virtual Bioequivalence Assessment to Support Formulation Development
Mechanistic Absorption and PK modeling using GastroPlus®
Annual Shareholders’ Meeting
Our mission is to improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services
Simulations Plus to Present at the 22nd Annual Needham Growth Conference
Simulations Plus to Present at the 22nd Annual Needham Growth Conference
LD Micro 12th Annual Main Event Investor Conference
Our mission is to improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services
QSP/QST Modeling Support for NASH Drug Development
Quantitative Systems Pharmacology (QSP) Supports Clinical Development by Emphasizing Mechanistic Understanding of Pathophysiology and Treatment
Benchmark 8th Annual Discovery Conference
Our mission is to improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services
Mechanistic Insights into Drug-Induced Liver Injury for Macrolide Antibiotics using Quantitative Systems Toxicology Modeling
DILIsym Services Is Using QSP and QST Modeling to Predict Efficacy and Safety of Drugs in Development